Sophia Genetics and AstraZeneca collaborate to expand liquid biopsy test rollout
Under the collaboration, AstraZeneca will support the rollout of MSK-ACCESS to 20 global locations over the next 12 months.
Under the collaboration, AstraZeneca will support the rollout of MSK-ACCESS to 20 global locations over the next 12 months.
The AI model can accurately predict who is at a high risk of developing sight-threatening diabetic retinopathy up to three years in advance.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Alio starts trial to expand label for remote monitoring device
Firefly and Zeto team up to distribute EEG headset devices
AstraZeneca eyes up transition to eco-friendly inhaler propellant
Exer AI and Mayo Clinic unite to treat hand and wrist disorders using AI